121 related articles for article (PubMed ID: 29128422)
1. Ampholytic starch excipients for high loaded drug formulations: Mechanistic insights.
Sakeer K; Ispas-Szabo P; Benyerbah N; Mateescu MA
Int J Pharm; 2018 Jan; 535(1-2):201-216. PubMed ID: 29128422
[TBL] [Abstract][Full Text] [Related]
2. Self-Stabilizing Ampholytic Starch Excipients for Sustained Release of Highly Soluble Drugs: the Case Study of Metformin.
Sakeer K; Ispas-Szabo P; Mateescu MA
AAPS PharmSciTech; 2017 Oct; 18(7):2658-2672. PubMed ID: 28271374
[TBL] [Abstract][Full Text] [Related]
3. Cross-linked high amylose starch derivatives as matrices for controlled release of high drug loadings.
Mulhbacher J; Ispas-Szabo P; Lenaerts V; Mateescu MA
J Control Release; 2001 Sep; 76(1-2):51-8. PubMed ID: 11532312
[TBL] [Abstract][Full Text] [Related]
4. Carboxymethyl Starch Excipients for Drug Chronodelivery.
Ispas-Szabo P; De Koninck P; Calinescu C; Mateescu MA
AAPS PharmSciTech; 2017 Jul; 18(5):1673-1682. PubMed ID: 27686941
[TBL] [Abstract][Full Text] [Related]
5. Ampholytic and Polyelectrolytic Starch as Matrices for Controlled Drug Delivery.
Benyerbah N; Ispas-Szabo P; Sakeer K; Chapdelaine D; Mateescu MA
Pharmaceutics; 2019 Jun; 11(6):. PubMed ID: 31159403
[TBL] [Abstract][Full Text] [Related]
6. The influence of protonation ratio on properties of carboxymethyl starch excipient at various substitution degrees: Structural insights and drug release kinetics.
Assaad E; Mateescu MA
Int J Pharm; 2010 Jul; 394(1-2):75-84. PubMed ID: 20435114
[TBL] [Abstract][Full Text] [Related]
7. Carboxymethyl starch and lecithin complex as matrix for targeted drug delivery: I. Monolithic mesalamine forms for colon delivery.
Mihaela Friciu M; Canh Le T; Ispas-Szabo P; Mateescu MA
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):521-30. PubMed ID: 23562535
[TBL] [Abstract][Full Text] [Related]
8. Spray-dried high-amylose sodium carboxymethyl starch: impact of α-amylase on drug-release profile.
Nabais T; Zaraa S; Leclair G
Drug Dev Ind Pharm; 2016 Nov; 42(11):1887-93. PubMed ID: 27109692
[TBL] [Abstract][Full Text] [Related]
9. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
Brouillet F; Bataille B; Cartilier L
Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
[TBL] [Abstract][Full Text] [Related]
10. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
[TBL] [Abstract][Full Text] [Related]
11. Two release rates from monolithic carboxymethyl starch tablets: formulation, characterization, and in vitro/in vivo evaluation.
Le TC; Mateescu MA
Drug Deliv Transl Res; 2017 Aug; 7(4):516-528. PubMed ID: 28386870
[TBL] [Abstract][Full Text] [Related]
12. Polyelectrolyte complex of carboxymethyl starch and chitosan as protein carrier: oral administration of ovalbumin.
Assaad E; Blemur L; Lessard M; Mateescu MA
J Biomater Sci Polym Ed; 2012; 23(13):1713-28. PubMed ID: 21967707
[TBL] [Abstract][Full Text] [Related]
13. Carboxymethyl high amylose starch as excipient for controlled drug release: mechanistic study and the influence of degree of substitution.
Lemieux M; Gosselin P; Mateescu MA
Int J Pharm; 2009 Dec; 382(1-2):172-82. PubMed ID: 19716866
[TBL] [Abstract][Full Text] [Related]
14. Novel multifunctional pharmaceutical excipients derived from microcrystalline cellulose-starch microparticulate composites prepared by compatibilized reactive polymer blending.
Builders PF; Bonaventure AM; Tiwalade A; Okpako LC; Attama AA
Int J Pharm; 2010 Mar; 388(1-2):159-67. PubMed ID: 20060448
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of dibutyrylchitin as new excipient for sustained drug release.
Casettari L; Cespi M; Castagnino E
Drug Dev Ind Pharm; 2012 Aug; 38(8):979-84. PubMed ID: 22124336
[TBL] [Abstract][Full Text] [Related]
16. Partial least square projections to latent structures analysis (PLS) in evaluating and predicting drug release from starch acetate matrix tablets.
Korhonen O; Matero S; Poso A; Ketolainen J
J Pharm Sci; 2005 Dec; 94(12):2716-30. PubMed ID: 16258997
[TBL] [Abstract][Full Text] [Related]
17. Carboxymethyl starch: Chitosan monolithic matrices containing diamine oxidase and catalase for intestinal delivery.
Calinescu C; Mondovi B; Federico R; Ispas-Szabo P; Mateescu MA
Int J Pharm; 2012 May; 428(1-2):48-56. PubMed ID: 22402476
[TBL] [Abstract][Full Text] [Related]
18. Self-stabilized chitosan and its complexes with carboxymethyl starch as excipients in drug delivery.
Leonida M; Ispas-Szabo P; Mateescu MA
Bioact Mater; 2018 Sep; 3(3):334-340. PubMed ID: 29988516
[TBL] [Abstract][Full Text] [Related]
19. Anthocyanins Formulated with Carboxymethyl Starch for Gastric and Intestinal Delivery.
De Sousa Sabino LB; Copes F; Saulais S; De Brito ES; Da Silva Júnior IJ; Le TC; Mateescu MA; Mantovani D
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364096
[TBL] [Abstract][Full Text] [Related]
20. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
Lin SY; Lin KH; Li MJ
J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
